Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction

Michel Chonchol1, Ilan Goldenberg, Arthur J Moss

  • 1Division of Renal Diseases and Hypertension, University of Colorado Health Sciences Center, Denver, Colo. 80262, USA. Michel.Chonchol@uchsc.edu

Insights

Mild chronic renal insufficiency significantly increases sudden cardiac death (SCD) risk in patients with left ventricular dysfunction. Beta-blocker therapy can reduce this risk, improving outcomes for heart failure patients with kidney issues.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Medicine

Background:

  • Patients with ischemic left ventricular dysfunction face a high risk of sudden cardiac death (SCD).
  • The impact of mild chronic renal insufficiency on SCD risk and its predictors in these patients remains unclear.

Purpose of the Study:

  • To investigate the association between mild renal dysfunction and SCD risk in patients with ischemic left ventricular dysfunction.
  • To identify risk factors for SCD in patients with coexisting renal insufficiency and left ventricular dysfunction.
  • To evaluate the effect of beta-blocker therapy on SCD risk in this population.

Main Methods:

  • Post-hoc analysis of the Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) conventional medical therapy arm.
  • Mild renal dysfunction defined as estimated glomerular filtration rate (eGFR) <75 ml/min/1.73 m2.
  • Multivariable analysis to assess independent predictors and associations.

Main Results:

  • Renal dysfunction was independently associated with increased risks of all-cause mortality (HR=1.86) and SCD (HR=2.00).
  • Independent predictors of SCD in patients with renal dysfunction included increased resting heart rate, low diastolic blood pressure, and prolonged QRS duration.
  • Beta-blocker therapy was associated with a significant reduction in SCD risk (HR=0.61) in patients with eGFR <75 ml/min/1.73 m2.

Conclusions:

  • Mild renal dysfunction significantly elevates SCD risk in patients with left ventricular dysfunction.
  • Beta-blocker therapy demonstrates a protective effect against arrhythmic mortality in heart failure patients with coexisting renal insufficiency.
Abstract

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...